Бримонидин Тева

Country: Իսրայել

language: ռուսերեն

source: Ministry of Health

active_ingredient:

BRIMONIDINE TARTRATE 0.15 %W/V

MAH:

TEVA PHARMACEUTICAL INDUST.LTD

ATC_code:

S01EA05

pharmaceutical_form:

OPHTHALMIC SOLUTION

administration_route:

OCULAR

manufactured_by:

TEVA PHARMACEUTICAL INDUSTRIES LTD

therapeutic_group:

BRIMONIDINE

therapeutic_indication:

For the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

authorization_date:

2009-12-01